Interim considerations : Preparing for the potential management of anaphylaxis after COVID-19 vaccination

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

Interim considerations : Preparing for the potential management of anaphylaxis after COVID-19 vaccination

03/01/2021
By National Center for Immunization and Respiratory Diseases (U.S.)

[PDF-160.63 KB]

English

Details Supporting Files You May Also Like

Details:

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.)
Description:

A serious allergic reaction (e.g., anaphylaxis) after a previous dose or to a component of a COVID-19 vaccine or an immediate allergic reaction of any severity after a previous dose or known (diagnosed) allergy to a component of a COVID-19 vaccine are contraindications to vaccination.

03/01/2021 CS321629-G

IntermConsid-Anaphylaxis-covid19-vaccine-sites.pdf
Content Notes:

Overview -- Personnel, medications, and supplies for assessing and managing anaphylaxis -- Routine observation periods following COVID-19 vaccination -- Early recognition of anaphylaxis -- Management of anaphylaxis at a COVID-19 vaccination location -- Considerations for anaphylaxis management in special populations -- Patient counseling -- Reporting anaphylaxis -- Additional resources -- References -- Previous Updates.
Subjects:

[+]

Anaphylaxis Coronavirus Infections/prevention & Control COVID-19 Vaccines/adverse Effects Pandemics Vaccination Viral Vaccines
Document Type:

Webpage
Pages in Document:

3 unumbered pages
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:9e105f0b7b248df73bf12e1c4f83b81d4fe470e048669fd2bcf2ca8b86596db7
Download URL:

https://stacks.cdc.gov/view/cdc/106313/cdc_106313_DS1.pdf
File Type:

managing-anaphylaxis.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fcovid-19%2Finfo-by-product%2Fpfizer%2Fanaphylaxis-management.html

htm

More +